Procurement Analytics Market is Projected to Grow at a Strong CAGR of 22.5% through 2032 | FMI

The procurement analytics market is expected to develop at a CAGR of 22.5% from 2022 to 2032, with revenues estimated at USD 3.3 billion in 2022. The market is estimated to be worth USD 24.8 billion by the end of 2032. As SMEs’ revenue has increased, they have begun to invest in technology to optimise their supply chain and reduce operational expenses.

The World Bank estimates that SMEs make up about 90% of all enterprises and more than half of all jobs worldwide. Up to 40% of the national income in emerging economies comes from formal SMEs. With a persistent focus on dashboards, reporting, and advanced visualisation, SMEs have prioritised big data, governance, and data catalogues.

Procurement Analytics assists SMEs in automating their processes by saving time and money while enhancing productivity and efficiency. It also focuses on core activities rather than regular business tasks, allowing it to focus on what matters most. It also aids in client communication and the creation of a digital presence, which helps SMEs differentiate themselves from their competition at a low cost.

Get the Complete Story—Read More About Our Latest Report!

Key Takeaways from the Market Study 

  • Global Procurement Analytics Market is expected to reach a valuation of USD 3.3 Billion by 2022.
  • The Supply Chain Analytics segment is expected to account for the highest CAGR rate of 22.1% during the forecast period.
  • United States is projected to remain the most dominant market with an absolute dollar growth opportunity of USD 7.6 Billion during 2022 – 2032.
  • The market in the US is set to experience the highest CAGR of 22.3% during 2022-2032.

Competitive Landscape:

The market is fiercely competitive, where key players are increasingly focused to obtain a competitive advantage. The key companies in the Procurement Analytics Market are focused on R&D to produce innovative technological solutions.

  • In April 2022, Kraft Heinz Business and Microsoft Corp. established a partnership to create solutions to help consumer products be more robust in their supply chain. The endeavour is a key driver of Kraft Heinz’s ambitious AGILE SCALE strategy, and it is one of the company’s largest technology investments at present.
  • In March 2022, HSBC and IBM announced today that they will collaborate to investigate quantum computing applications in financial services. The new three-year agreement seeks to boost HSBC’s quantum computing skills and ensure the bank’s preparedness to fully implement the technology.

Key Players

  • Microsoft Corp.
  • SAP SE
  • IBM Corp
  • Oracle Corp.
  • Cisco Systems Inc.
  • Amazon Web Service Inc.
  • SAS Institute Inc.
  • Coupa Software Inc.
  • Rosslyn Data Technologies Inc.
  • Zycus Inc.

Procurement Analytics Market Segmentation:

By Component:

  • Solutions
  • Services

By Application:

  • Supply Chain Analytics
  • Risk Analytics
  • Spend Analytics
  • Demand Forecasting
  • Contract Management

By Deployment Mode:

  • Cloud based Procurement Analytics Solutions
  • On-premises Procurement Analytics Solutions

By Organization Size:

  • Large Enterprises
  • Small and Medium-sized Enterprises (SMEs)

By Industry Vertical:

  • BFSI
  • Retail and e-Commerce
  • Telecom and IT
  • Manufacturing
  • Healthcare and Life Sciences
  • Energy and Utilities
  • Government and defence

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:     

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Vascular Access Catheters Market Set to Reach USD 5.3 Billion by 2032

The global vascular access catheters market is projected to witness significant growth, with the market valuation expected to reach USD 5.3 billion by 2032, up from an estimated USD 3.0 billion in 2022, according to a recent report by Future Market Insights. This growth represents a steady compound annual growth rate (CAGR) of 5.7% over the forecast period from 2022 to 2032.

Several key factors are driving this expansion, including a rising demand for advanced medical technologies, the growing prevalence of chronic diseases, and an increasing need for efficient vascular access devices in critical care settings. Vascular access catheters are essential in modern healthcare, playing a pivotal role in treatments such as dialysis, chemotherapy, and intravenous medication administration.

Key Drivers of Market Growth:

  • Minimally Invasive Procedures: The increasing preference for minimally invasive techniques is driving the widespread adoption of vascular access catheters in medical procedures.
  • Technological Advancements: Innovations in catheter design are enhancing patient outcomes by reducing infection risks and improving overall efficiency.
  • Healthcare Expenditure: The rise in global healthcare spending and increased investments in healthcare infrastructure are further contributing to the market’s expansion.

As the market continues its upward trajectory, industry leaders are focusing on research and development to enhance their product offerings and meet the evolving needs of healthcare professionals. This robust growth forecast underscores the critical importance of vascular access catheters in modern medical practices and highlights the significant opportunity for innovation in this space.

Key Takeaways:

  • The rising implementation of tip location devices has enhanced the accuracy and efficiency of PICC and CVC insertion by helping physicians to position the PICC and CVC tip in proximity to the cardio arterial and large vein junction.
  • Rising demand for central venous catheters combined with favorable support from various government bodies on the basis of reimbursement and commercialization of novel interventional solutions are major factors boosting collaborations and partnership agreements between manufacturers.
  • Prominent companies within the central access devices market are making hefty investments to introduce innovative central venous catheters that will help in capitalizing. Therefore, creating lucrative opportunities in the vascular access catheters market. Also, companies are working on key related issues such as the prevention of thrombus formation and infection by introducing catheters with antimicrobial coatings.
  • The above-mentioned factors incorporate great prospects for manufacturers in order to elevate the adoption of their products to create a strong consumer base and boost the vascular access catheters market in the forecast years.

Explore the High Demand for Vascular Access Catheters: Our Full Report Provides a Detailed Look at Emerging Trends!

Competitive Landscape:

Several advancements in biocompatibility, flexibility, and the adoption of novel materials are efficiently shaping the demand for such effective and quality products in the vascular access catheters market. Key market players in the market are looking forward to expanding their market and creating a stronghold in the consumer base from long-term vascular access catheters (VACs). Manufacturers have benefitted from the growing understanding of the diagnosis of VAC-related infections. Technological advancements especially concerning designs and materials have enabled healthcare workers to overcome complex VAC infections and complications. These factors are the prospects of new technologies in the vascular access catheter market.

Angio Dynamics, C.R. Bard, Teleflex Incorporated, Kimal, B. Braun Melsungen AG, Vygon (UK) Ltd., Fresenius Kabi AG, Becton, Dickinson and Company, Argon Medical Devices, Inc., Boston Scientific Corporation, Cook Medical Incorporated, Medical Components, Inc., Medtronic PLC., Terumo Medical Corporation, NIPRO Medical Corporation, Angio dynamics, Edwards Lifesciences Corporation.

Key Market Segments Covered in Vascular Access Catheters Industry Research:

Products:

  • Dialysis Catheters
    • Acute Hemodialysis Catheters
    • Chronic Hemodialysis Catheters
    • Peritoneal Dialysis Catheters
  • PICC Catheters
  • Implantable Port
  • CVC Catheters
    • Tunneled Catheters
    • Non-Tunneled Catheters

Property:

  • Antimicrobial Catheters
  • Non-Antimicrobial Catheters

Design:

  • Single Lumen
  • Double Lumen
  • Multiple Lumen

End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Dialysis Centers
  • Specialty Clinics and Others

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Non-Surgical Fat Reduction Market Set for Remarkable Growth, Reaching USD 2932.3 Million by 2034, Growing at a 5.6% CAGR

The global non-surgical fat reduction market is on the brink of a significant transformation, with projections indicating a surge in valuation from USD 1,700.5 million in 2024 to an impressive USD 2,932.3 million by 2034. This robust growth reflects a compound annual growth rate (CAGR) of 5.6% over the forecast period, highlighting the increasing demand for non-invasive body contouring solutions.

As consumer awareness of non-surgical cosmetic treatments rises, more individuals are turning to these effective alternatives to traditional surgical procedures. Non-surgical fat reduction techniques, including cryolipolysis, ultrasound, and laser treatments, are becoming increasingly popular in aesthetic clinics around the world. These methods offer patients the benefit of achieving their body goals without the downtime or risks commonly associated with surgery.

Several key factors are driving this market expansion. A surge in disposable income among consumers allows for greater investment in personal aesthetics, while advancements in fat reduction technologies are delivering improved outcomes with fewer side effects. Industry experts anticipate that as innovation continues and investments in the cosmetic sector increase, the variety of non-invasive fat reduction options will further grow, appealing to a broader audience.

“The non-surgical fat reduction market is evolving rapidly, with technological advancements paving the way for safer and more effective treatments,” said opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI). “As consumers become more educated about their options, we expect to see sustained growth and a wider acceptance of these innovative solutions.”

With a focus on enhancing patient satisfaction and delivering tangible results, the non-surgical fat reduction market is poised to redefine body contouring and reshape the landscape of cosmetic treatments.

Key Takeaways from the Market Study:

  • From 2019 to 2023, the non surgical fat reduction market expanded at a CAGR of 10.30%.
  • Based on the technique, the cryolipolysis segment is expected to account for a market share of 33.50%
  • The demand for non surgical fat reduction in the Germany is predicted to grow at a CAGR of 3.10% through 2034.
  • In the United States, the non surgical fat reduction industry is estimated to register a CAGR of 1.7% from 2024 to 2034.
  • China is projected to expand by a CAGR of 1.8% between 2024 and 2034.
  • The non surgical fat reduction market in Japan is anticipated to record a CAGR of 0.90% during 2034.

Competitive Landscape:

The market players in the nonsurgical fat reduction market are investing in research and development to create innovative nonsurgical fat reduction techniques that offer improved results, shorter treatment time, and enhanced patient comfort. The market layers are collaborating with healthcare providers, aesthetic clinics and distribution partner to expand their market reach.

  • In January2021 – Allergan Aesthetics has announced the release of CoolSculpting® Elite, a next-generation fat-loss technology whose applicators enhance the body’s natural contours. Targeting, freezing, and eradicating treated fat cells is possible with CoolSculpting® Elite because to its proven CoolSculpting® technology.
  • The FDA has approved CoolSculpting® Elite to treat noticeable fat bulges in nine different body sites, including the flank, thigh, and abdomen; bra fat, back fat, upper arm, beneath the buttocks (sometimes called the banana roll); and the submental and submandibular regions.

Non-Surgical Fat Reduction Market Trends: Discover the Full Details in Our Extensive Report!

Key Companies Profiled:

  • Valeant Pharmaceuticals International Inc.
  • Allergan plc
  • Alma Lasers
  • Cynosure, Inc.
  • Sciton, Inc.
  • Solta Medical Inc.
  • Lumenis Ltd.
  • Syneron Medical Ltd.
  • Lutronic Corporation
  • Lynton Lasers Ltd.
  • Cutera Inc.

Key Market Segments Covered in the Non Surgical Fat Reduction Industry Research:

By Technique:

  • Cryolipolysis
  • Ultrasound
  • Low-Level Lasers
  • Others

By End User:

  • Hospitals
  • Plastic Surgery Centers
  • Cosmetic and Aesthetic Clinics

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia and Pacific
  • East Asia
  • The Middle East and Africa

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

Explore FMI’s related ongoing Coverage on Healthcare Market Insights Domain:

The weight loss and obesity management market size is projected to rise at a CAGR of 12.8% during the projected period. The market value is projected to increase from USD 14,511 million in 2024 to USD 48,396 million by 2034.

The obesity management market share is expected to expand with a CAGR of 5.2% during the forecast period from 2023 to 2033. The overall market value is projected to grow from USD 2,095.6 million in 2023 to USD 3,494.5 million by 2033.

The body fat reduction market demand is expected to expand its roots at a steady CAGR of 9.6% during the forecast period. The market is likely to hold a revenue of USD 10.65 billion in 2023 while it is anticipated to cross a value of USD 25.6 billion by 2033.

The global HIV diagnostics market growth is estimated to be worth USD 3,497.2 million in 2024 and anticipated to reach a value of USD 7,207.7 million by 2034. Sales are projected to rise at a CAGR of 7.5% over the forecast period between 2024 and 2034.

The contact-lens induced infections market outlook is estimated to reach USD 491.3 million in 2024. It is estimated that revenue will increase at a CAGR of 4.9% between 2024 and 2034. The market is anticipated to reach USD 792.6 million by 2034.

The self-administered biologics market overview is estimated to reach USD 94,057.6 million in 2024. It is estimated that revenue will increase at a CAGR of 4.5% between 2024 and 2034. The market is anticipated to reach USD 146,068.5 million by 2034.

The global patient transportation market sales is estimated to be worth USD 22,035.5 million in 2024 and anticipated to reach a value of USD 37,639.9 million by 2034. Sales are projected to rise at a CAGR of 5.5% over the forecast period between 2024 and 2034.

The global vascular patches market forecast is estimated to be worth USD 160.3 million in 2024 and anticipated to reach a value of USD 256.2 million by 2034. Sales are projected to rise at a CAGR of 4.8% over the forecast period between 2024 and 2034.

The MENA syringes & cannula market opportunity are estimated to be worth USD 1,592.2 million in 2024 and are anticipated to reach a value of USD 2,824.7 million by 2034. Sales are projected to rise at a CAGR of 5.9% over the forecast period between 2024 and 2034.

The carbon dioxide incubators market strategies is estimated to reach USD 752.9 million in 2024. It is estimated that revenue will increase at a CAGR of 5.1% between 2024 and 2034. The market is anticipated to reach USD 1,238.1 million by 2034.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Flow Cytometry Market Poised for Remarkable Growth: Projected to Reach USD 12,661.7 Million by 2034, Driven by AI and Machine Learning Integration

The global flow cytometry market is on the brink of a significant transformation, with projections indicating a surge in value over the next decade. According to recent market analysis, the industry is expected to expand from USD 6,376.7 million in 2024 to an impressive USD 12,661.7 million by 2034, translating to a compound annual growth rate (CAGR) of 7.1%. This remarkable growth highlights the sector’s burgeoning potential and increasing attractiveness to investors and stakeholders worldwide.

Flow cytometry, a critical technology used for cell analysis, sorting, and characterization, has become indispensable in fields such as immunology, cancer research, and drug development. Several key factors are driving this surge in market value:

  1. Technological Advancements: Continuous innovations in flow cytometry technology, including the development of high-throughput systems and improved reagents, are enhancing the capabilities of researchers and clinicians, thereby expanding the market’s applications.
  2. Increased Research Funding: The rise in research funding from governmental and private organizations is fueling the development of new flow cytometry applications, particularly in cancer and immunological research.
  3. Expanding Applications: The growing utilization of flow cytometry in various sectors—such as drug discovery and development, diagnostic testing, and clinical research—is driving demand for advanced cytometry solutions.
  4. Rising Awareness: Increased awareness of the benefits of flow cytometry in early disease detection and personalized medicine is contributing to the market’s growth.

As the global flow cytometry market evolves, it presents a wealth of opportunities for innovation and investment. Industry stakeholders and investors are well-positioned to capitalize on this growth trajectory, with advancements in technology and increasing demand set to drive further expansion.

Key Takeaways from the Flow Cytometry Market Report:

  • The reagents, consumables, and accessories product type segment occupied 54.7% of the market shares in 2024.
  • The biopharmaceutical companies segment captured 50.2% of the market share in 2024.
  • The market size in the United States is projected to rise at an 8.9% CAGR through 2034.
  • The market size in Germany is anticipated to develop at a 7.3% CAGR through 2034.
  • The market size in India is estimated to surge at an 8.2% CAGR through 2034.
  • The market size in China is expected to thrive at a 9.1% CAGR through 2034.

Note from the Analysts:

“Mastering the flow cytometry market necessitates a thorough awareness of client preferences, a commitment to innovation, stringent regulatory compliance, and strategic collaboration. Success in this changing environment requires a comprehensive approach emphasizing adaptability, inventiveness, and a strong commitment to sustainability.” Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)

Get the Latest on Flow Cytometry: Our Full Report Highlights Key Trends and Insights!

Competitive Landscape:

A combination of well-established leaders and emerging businesses define the competitive landscape of the flow cytometry market. Global reach and complete solutions are the defining characteristics of dominant firms like Beckman Coulter, Thermo Fisher Scientific, and BD Biosciences. New entrants concentrate on specialized markets or cutting-edge technology. It is usual to encounter strategic alliances that promote innovation and commercial development. Competition is shaped by technological developments, especially the incorporation of artificial intelligence.

Recent Developments:

  • In June 2023, BD (Becton, Dickinson, and Company) launched a flow cytometry-based equipment for clinical diagnostics. This equipment provides a comprehensive “walkaway” workflow solution for improving repeatability and consistency in cellular diagnostics.
  • In February 2023, IDEX Health & Science (IH&S) introduced the new Semrock ® Nanopede™ Optical Filters for flow cytometry.

Key Players in the Flow Cytometry Market:

  • BD Biosciences
  • Beckman Coulter (a subsidiary of Danaher Corporation)
  • Thermo Fisher Scientific
  • Sony Biotechnology Inc.
  • Sysmex Partec GmbH
  • Miltenyi Biotec
  • Luminex Corporation
  • Agilent Technologies
  • Bio-Rad Laboratories, Inc.
  • Cytek Biosciences, Inc.

Flow Cytometry Market Segmentation:

By Product Type:

  • Flow Cytometer System
    • Tradition Flow Cytometer
      • Cell Sorters
      • Imaging Flow Cytometers
  • Acoustic Focusing Cytometers
  • Next-Generation Flow Cytometers
  • Reagents, Consumables & Accessories
  • Software
  • Services

By Application:

  • Immunophenotyping
  • Cell Sorting
  • Cell Cycle Analysis
    • Apoptosis
    • Cell Proliferation Assays
    • Intracellular Calcium Flux
  • Detection & Sorting of Exosomes
  • Others

By Usage:

  • Research Use
  • Clinical Diagnostics

By End User:

  • Hospitals
  • Diagnostic Laboratories
  • Academic and Research Institute
  • Biopharmaceutical Companies

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific (APAC)
  • Middle East & Africa (MEA)
  • Japan

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Spinal Fusion Market Set for Significant Growth, Projected to Reach USD 16,771.8 Million by 2033, Fueled by Robust Growth Projections

The global spinal fusion market is on the brink of substantial expansion, with recent projections forecasting a remarkable increase in valuation. According to the latest analyses, the market is expected to soar to USD 16,771.8 million by 2033, reflecting a robust compound annual growth rate (CAGR) of 5.4%, up from an estimated USD 9,945.5 million in 2023.

This upward trajectory underscores the rising demand for advanced surgical procedures and technologies to treat spinal disorders. Key factors driving this growth include the increasing prevalence of spinal disorders, advancements in surgical techniques, and the rising adoption of minimally invasive procedures.

Investment and innovation are flourishing within the spinal fusion market, with leading companies focusing on developing cutting-edge technologies to tackle complex spinal conditions. The expansion is further fueled by the growing aging population, which necessitates effective treatment options for spinal injuries and degenerative diseases.

Key Growth Drivers:

  • Technological Advancements: Continuous R&D efforts are leading to the introduction of advanced technologies that enhance treatment efficacy and patient outcomes.
  • Expanding Treatment Options: A diverse array of treatment options allows for more personalized care, improving accessibility and patient satisfaction.
  • Rising Geriatric Population: The growing elderly population demands solutions for age-related spinal conditions, fueling market growth.
  • Minimally Invasive Solutions: The preference for minimally invasive procedures is reshaping spinal fusion treatments and driving market expansion.

High Demand for Spinal Fusion: Uncover the Trends and Insights with Our Detailed Report!

Competitive Landscape:

The spinal fusion market is expected to be highly competitive and fragmented, with numerous players across the globe. Key market participants are likely to employ strategies such as collaborations, partnerships, mergers, acquisitions, and new product launches to meet consumer demand and expand their market presence. Additionally, governmental investments in spinal fusion equipment are anticipated to further support market growth.

Recent Advances in the Spinal Fusion Market

  • In August 2022, Wenzel Spine, Inc. announced the launch of the S-LIF Procedure for Stand-alone Lumbar Interbody Fusion, featuring the VariLift®-LX device. This device is the first FDA-approved single-level extendable anterior fusion solution for the lumbar interbody.
  • In June 2022, Aurora Spine received FDA 510(k) approval for its DEXA SOLO-L posterior fusion device designed for the lumbar spine.
  • Additionally, in May 2022, Accelus introduced the TiHawk7™ extendable interbody cage and performed its first surgeries. The TiHawk7 is the latest addition to Accelus’ FlareHawk® Interbody Fusion System.

Key Companies Profiled:

  • Zimmer Biomet Holdings, Inc.
  • Stryker Corporation, Inc.
  • Exactech, Inc.
  • Medtronic Plc
  • Johnson & Johnson Services, Inc (Depuy Synthes)
  • Wenzel Spine, Inc.
  • Centinel Spine, Inc.
  • Spineart Geneva SA
  • K2M, Inc.
  • MicroPort Scientific Corporation
  • Integra Lifesciences Holdings Corp
  • Orthofix Holdings, Inc.
  • Shandong Weigao Group Medical Polymer Company Limited
  • Bonovo Orthopedics, Inc.

Regional Insights:

The U.S. is projected to lead the global market, holding approximately 88.6% of the market share in 2021, driven by a high prevalence of spinal cord injuries. Germany is expected to be the second-largest market, accounting for around 23.8% of the global share in 2021, with rising obesity rates contributing to increased demand for spinal fusion procedures.

Market Segments:

  • By Product: Interbody Cages, Pedicle Screws and Rods, Spinal Fusion Plates
  • By Procedure: Posterolateral Fusion, Interbody Fusion (ALIF, XLIF, PLIF, TLIF, Others)
  • By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centres
  • By Region: North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Laser Therapy Devices Market Projected to Surge to USD 7 Billion by 2033

The global laser therapy devices market is poised for exceptional growth over the next decade, according to a recent report by Future Market Insights (FMI). Valued at USD 3 billion in 2023, the market is forecasted to soar to an impressive USD 7 billion by 2033, reflecting a significant expansion driven by increasing adoption and diverse applications across medical sectors.

FMI’s comprehensive analysis projects a Compound Annual Growth Rate (CAGR) of 8.8% over the next decade, highlighting a robust upward trajectory in the market. This growth underscores the growing recognition of laser therapy’s efficacy and versatility, with applications spanning dermatology, orthopedics, and ophthalmology.

“This remarkable growth is a testament to the transformative impact of laser therapy in modern medicine,” said a representative from Future Market Insights. “The advancement in technology and its expanding applications are paving the way for significant market expansion.”

Key factors contributing to the anticipated surge in market value include technological innovations, rising healthcare awareness, and an increasing demand for non-surgical treatment options. As healthcare providers and patients alike seek effective and minimally invasive solutions, laser therapy devices are becoming integral to medical practice.

Key Drivers of Growth:

  • Technological Advancements: Continuous innovation in laser technology enhances the efficacy and safety of treatments, contributing to increased adoption.
  • Broadening Applications: The expanding use of laser therapy in various medical specialties drives demand and market expansion.
  • Rising Awareness: Increased awareness about the benefits of laser therapy among healthcare professionals and patients fuels market growth.

Future Market Insights projects that this growth will continue as new advancements in laser technology emerge and healthcare systems globally adopt more innovative treatments.

Market Trends and Regional Insights:

Device Type:

Gas laser therapy devices are expected to capture more than a quarter of the market revenue. Hospitals and specialty clinics will generate significant shares of the revenue, with ophthalmology treatments likely to dominate.

Regional Growth:

The US and UK are anticipated to experience high sales due to the popularity of LLLT, while Germany’s high prevalence of dermatological disorders and France’s robust healthcare research funding will further fuel market growth. China’s high plastic surgery rates are also expected to contribute significantly to market expansion.

Full Report On Laser Therapy Devices: Explore the Latest Trends and Insights in Our Detailed Analysis!

Competitive Landscape:

The market is highly competitive, with key players including:

  • Boston Scientific Corporation
  • IPG Photonics Corporation
  • Lumenis Ltd.
  • Coherent Inc.
  • Biolitec AG
  • Hologic Inc.
  • Alma Lasers Ltd.
  • Fotona D.D
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.

Are some prominent laser therapy devices manufacturers as profiled by FMI’s report? New product launches, capacity expansion initiatives and securing regulatory approvals for specific techniques are some key growth strategies.

  • In 2018, Hologic Inc. received a medical device license issued by Health Canada to market Cynosure’s advanced non-invasive body contouring product called SculpSure®, a laser treatment device for treating back, inner and outer thighs, and submental area under the chin. This approach destroys fat cells by raising body fat temperature.
  • Recently, in April 2021, Alma Lasers Ltd. launched the Alma PrimeXTM platform, a non-invasive approach for body contouring and skin tightening in the abdomen, waist, thighs and buttock areas. It deploys a combination of ultrasound and radiofrequency technologies.

Key Segments Covered:

Device Type:

  • Solid-State Laser
  • Gas Laser
  • Liquid Laser
  • Semiconductor Laser

End-User:

  • Hospitals
  • Specialized Clinics
  • Ambulatory Surgical Centers
  • Other End-Users

Application:

  • Ophthalmology
  • Dermatology
  • Gynecology
  • Urology
  • Cardiovascular
  • Others

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Sports Medicine Market Set to Reach USD 2,062.7 Million by 2033, Driven by Mental Health Focus

The global sports medicine market is experiencing remarkable growth, driven by an unprecedented emphasis on mental health within the sports industry. Recent market analysis indicates that the sports medicine market is on track to achieve a valuation of USD 1,157.0 million by the end of 2023. This significant milestone comes as the market is projected to expand at a Compound Annual Growth Rate (CAGR) of 6.0% from 2023 to 2033, ultimately reaching an impressive USD 2,062.7 million by 2033.

The surge in market growth can be attributed to the increasing recognition of the critical role mental health plays in athletic performance and overall well-being. As sports organizations and professionals prioritize mental health alongside physical health, there has been a corresponding rise in demand for specialized sports medicine solutions that comprehensively address both aspects.

Key Factors Driving Market Growth:

  • Increased Awareness of Mental Health: The sports industry is placing greater emphasis on mental well-being, leading to higher demand for sports medicine products and services that support mental health.
  • Advancements in Sports Medicine Technology: Innovations in sports medicine technology are enhancing the efficacy of treatments and interventions, significantly contributing to market expansion.
  • Rising Participation in Sports and Fitness Activities: A growing global interest in sports and fitness is driving the need for advanced sports medicine solutions to manage and prevent injuries.
  • Supportive Regulatory Environment: Favorable regulations and policies are facilitating the development and adoption of sports medicine products.

“Today’s sports medicine market is evolving rapidly, driven by a greater understanding of the interplay between mental and physical health,” said a representative from FMI. “The projected growth reflects a broader trend of integrating comprehensive health solutions for athletes, which is vital for their overall performance and well-being.”

As the market continues to grow, stakeholders are encouraged to leverage this momentum to develop innovative solutions that prioritize the holistic health of athletes. The future of sports medicine is promising, with a focus on enhancing both physical and mental performance.

Key Takeaways from the Market Study:

  • Global sports medicine market was valued at USD 1,078.0 million by 2022-end.
  • From 2018 to 2022, the market demand expanded at a CAGR of 7.4%.
  • The market in India is expected to expand at a CAGR of 8.9% through 2033.
  • By product type, the standalone analyzers segment to account for a share of 55.9% in 2023.
  • From 2023 to 2033, sports medicine market is expected to flourish at a CAGR of 6.0%.
  • By 2033, the market value of sports medicine is expected to reach USD 2,062.7 million.

There is a shift towards patient centric approaches in sports medicine, emphasizing shared decision making, patient education, and engagement. Healthcare providers are focusing on creating personalized treatment plans that align with the preferences and lifestyles of patients, remarks an FMI analyst.

Understand the Surge in Sports Medicine: Our Comprehensive Report Offers Essential Trends and Insights!

Competitive Landscape:

Prominent players in the sports medicine market are Arthrex, Inc., DePuy Synthes, Smith & Nephew Plc., Stryker Corporation, Zimmer Biomet Holdings, Inc., Olympus Movement Performance, Karl Storz, Tornier N.V., Wright Medical Group N.V., DJO Global, Ossur HF, Medtronic Plc., CONMED Corporation, Mueller Sports Medicine, Inc., Cayenne Medical, NuOrtho Surgical Inc., Ottobock, RTI Surgical, and NuVasive, Inc., among others.

Recent Developments:

  • In 2023, Medtronic plc announced the launch of its new MyoSure Ablation System for sports medicine applications. The MyoSure system is designed to treat pain caused by muscle and nerve injuries.
  • In the same year, Arthrex, Inc. announced the launch of its new Augmenix Augmented Reality System for sports medicine applications. The Augmenix system is designed to help surgeons visualize anatomy during surgery.
  • In 2022, Abbott Laboratories announced the launch of its new FreeStyle Libre 3 Glucose Monitoring System for sports medicine applications. The FreeStyle Libre 3 system is designed to help athletes track their blood glucose levels.
  • In 2022, Boston Scientific Corporation announced the launch of its new Vertiflex Intervertebral Spacer for sports medicine applications, which is designed to treat spinal stenosis.

Segmentation Analysis of the Sports Medicine Market:

By Product:

  • Body Reconstruction Products
    • Arthroscopy Devices
    • Meniscal Repair Device
    • Prosthetic Devices
    • Orthobiologics
  • Body Support and Recovery Products
    • Braces and Supports
    • Compression Clothing
    • Accessories

By Application:

  • Knee Injuries
  • Shoulder Injuries
  • Ankle and Foot Injuries
  • Back and Spine Injuries
  • Elbow and Wrist Injuries
  • Hip Injuries
  • Others

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia & Pacific
  • East Asia
  • The Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Microbial Identification Market Poised for Extraordinary Growth, Projected to Reach USD 10.7 Billion by 2032

The global microbial identification market is on the verge of remarkable expansion, according to a new study forecasting significant growth over the next decade. Valued at USD 3.7 billion in 2022, the market is projected to surge to an estimated USD 10.7 billion by 2032, reflecting a robust Compound Annual Growth Rate (CAGR) of 11.3%. This growth highlights the dynamic potential and resilience of the sector.

The rapid advancements in microbial identification technologies are driving this remarkable growth, along with an increasing demand for accurate and efficient microbial detection across various industries. The rising prevalence of infectious diseases and stringent regulatory requirements for microbial testing are further fueling market expansion.

Key factors contributing to this growth include advancements in molecular biology techniques and the rising adoption of microbial identification systems in clinical diagnostics. Additionally, the expansion of the pharmaceutical and biotechnology sectors, coupled with a growing focus on food safety and quality assurance, is expected to bolster demand for advanced microbial identification solutions.

As the market evolves, industry players are investing in innovative technologies and forming strategic partnerships to enhance their offerings and capture a larger share of this burgeoning market. The shift toward personalized medicine and precision diagnostics is also anticipated to play a significant role in shaping the future of microbial identification.

The key trends driving the global microbial identification market are:

  • Advancements in Technologies: Developments in areas like mass spectrometry, proteogenomics, microfluidics, and PCR assays are making microbial identification faster, more accurate, and even portable.
  • Focus on Product Quality: Governments worldwide are implementing stricter regulations for food, beverages, water, and pharmaceuticals. This creates a demand for reliable microbial identification to ensure product safety.
  • Increased R&D Investments: Growing investments in research and development are leading to the creation of new and improved microbial identification techniques.

Microbial Identification Trends Unveiled: Get a Complete Overview with Insights from Our Full Report!

Competitive Landscape:

The microbial identification market is highly fragmented due to numerous competitors in the field. To address consumer demand and grow their market share, companies are leveraging strategies such as mergers and acquisitions, partnerships, collaborations, and new product launches.

Here are some notable examples of key developmental strategies within the microbial identification industry:

  • In August 2022, Bruker Corporation introduced the nanoElute 2 nano-LC, MetaboScape, and TASQ 2023 software. These innovations support fluxomics and advanced PaSERs intelligent acquisition, aiming to advance research in protein-protein interactions (PPIs) and metaproteomics. The announcement was made at the International Mass Spectrometry Conference (IMSC 2022).
  • In June 2021, Danaher Corporation announced its acquisition of Aldevron, a privately held company, for approximately $9.6 billion in cash. Danaher plans to finance the acquisition using cash reserves and/or revenue from commercial paper.

Key Players:

  • Danaher Corporation
  • Bruker Corporation
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers
  • Shimadzu Corporation
  • QIAGEN N.V.
  • bioMerieux S.A.
  • Merck & Co Inc.
  • Biolog Inc.
  • Beckman Coulter
  • Wickham Laboratories
  • VWR International, LLC.
  • MIDI Inc.,
  • Siemens Healthcare
  • Charles River Laboratories Inc

Key Market Segments Covered in Microbial Identification Industry Research:

By Product:

  • Bacterial Identification Systems
  • Microbial Enumeration Systems
  • Bacterial Resistance Identification Systems
  • Microbiology Analyzers
  • Parasitology Analyzers

By Methods:

  • Phenotypic methods
  • Proteotypic Methods
  • Genotypic methods

By Application:

  • Diagnostic Application
  • Environmental Application
  • Food and Beverages Testing
  • Pharmaceutical Application
  • Others

By End User:

  • Pharmaceutical and Biotechnology Industry
  • Food and Beverage Industry
  • Water and Environment Industry
  • Independent Research Laboratories
  • Diagnostic Laboratories
  • hospitals
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Downstream Processing Market Set to Soar: Projected Growth USD 72.3 Billion by 2032

The global downstream processing market is on an impressive trajectory, with a projected valuation skyrocketing from USD 24.9 billion in 2022 to an astonishing USD 72.3 billion by 2032. This significant growth, representing a compound annual growth rate (CAGR) of 11.3% during the forecast period, underscores the critical importance of downstream processing in the biopharmaceutical industry.

Downstream processing plays a vital role in biopharmaceutical production, employing advanced techniques to purify and isolate desired molecules from complex biological mixtures. This process is essential for ensuring the safety, efficacy, and quality of biopharmaceutical products, which are increasingly sought after in today’s healthcare landscape.

The rapid expansion of the downstream processing market is primarily driven by the rising adoption of these solutions among biopharmaceutical companies and contract research organizations (CROs). As global demand for biopharmaceuticals surges—propelled by the need for innovative therapies and vaccines—the industry is witnessing remarkable advancements in bioprocessing technologies. These innovations are further accelerating market growth, solidifying downstream processing as an indispensable component of modern biopharmaceutical production.

With the market poised to reach USD 72.3 billion by 2032, stakeholders across the biopharmaceutical and CRO sectors stand to benefit significantly from the ongoing evolution of downstream processing technologies. This growth not only reflects the increasing prominence of biopharmaceuticals in global healthcare but also emphasizes the essential role of downstream processing in meeting stringent industry quality standards and production requirements.

Key Drivers of Market Growth:

  • Increased Demand for Biopharmaceuticals: The global demand for biopharmaceuticals, including vaccines and therapeutic proteins, is at an all-time high, necessitating efficient and scalable downstream processing solutions to meet production needs.
  • Rising Adoption by CROs: Contract research organizations are increasingly outsourcing downstream processing activities, further fueling market expansion.
  • Technological Advancements: Innovations in downstream processing technologies, such as single-use systems and continuous processing, are enhancing efficiency, reducing costs, and driving market growth.

This rapid market expansion presents significant opportunities for companies involved in the development and manufacturing of downstream processing products and services. As the market evolves, there will be a strong demand for innovative solutions that can address the complex and dynamic needs of biopharmaceutical companies and CROs.

Forecast Highlights:

  • Filters Product Segment: The filters product type segment is expected to reach a value of nearly USD 5.7 billion in 2022, accounting for more than one-fifth of the revenue share in the product type segment.
  • Contract Manufacturing Organizations: The contract manufacturing organizations segment is projected to achieve a value of approximately USD 5.5 billion in 2017, representing a significant share of the end-users segment.
  • Monoclonal Antibody Production: The monoclonal antibody production segment is forecasted to reach a value of about USD 8.3 billion by 2022, with North America contributing the largest share.
  • Gel Chromatography Segment: The gel chromatography segment is expected to exhibit a strong CAGR of nearly 15.0% from 2017 to 2022.

Explore the Growing Demand for Downstream Processing: Get All the Insights in Our Comprehensive Report!

Key Players in the Market:

Leading companies in the downstream processing market include Thermo Fisher Scientific Inc., GE Healthcare, Sartorius Stedim Biotech S.A., Merck Millipore, Danaher Corporation, and many others. These companies are at the forefront of innovation, driving advancements that will shape the future of downstream processing.

Market Segmentation:

  • By Product: Chromatography Columns and Resins, Membrane Adsorbers, Single-use Products, Consumables, and Accessories
  • By Technique: Separation, Concentration, Purification
  • By Application: Monoclonal Antibody Production, Vaccine Production, Insulin Production, Immunoglobulin Production, Erythropoietin Production, and Others
  • By End User: Biopharmaceutical Companies, CDMO/Contract Research Organization, Research/Academic Institutes
  • By Region: North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East, and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

On-the-Go Breakfast Products Market: Meeting the Needs of Modern Consumers | Future Market Insights, Inc.

In 2015, the global on-the-go breakfast products market was valued at nearly US$ 1,200 Mn, which is expected to reach US$ 1,500 Mn by 2021 end, registering a CAGR of 4.2% over the forecast period (2019 – 2026).

In today’s fast-paced world, leisurely breakfast meals are increasingly becoming a thing of the past. The rapid acceleration of daily life, especially in rapidly developing and developed countries, has driven a significant shift in dietary habits. As more people juggle demanding work schedules and longer commutes, the preference for convenient, on-the-go breakfast substitutes has surged. This trend is supported by extensive research conducted by Future Market Insights in 2019.

Key Drivers of Market Growth

The demand for on-the-go breakfast products is primarily driven by several critical factors:

  1. Fast-Paced Lifestyles: The global pace of life has reached unprecedented levels, leaving little time for traditional, sit-down breakfasts.
  2. Increased Workforce Participation: The growing participation of women in the workforce and longer commute times are significant contributors to the demand for quick and convenient breakfast options.
  3. Urbanization and Nuclear Families: The rise in urbanization and the prevalence of nuclear families require working women to balance domestic and professional responsibilities, leading to a preference for easy-to-consume breakfast products.

Market Valuation and Forecast

In 2015, the global on-the-go breakfast products market was valued at nearly USD 1,200 million. It is expected to reach approximately USD 1,500 million by the end of 2021, registering a compound annual growth rate (CAGR) of 4.2% over the forecast period from 2019 to 2026. By the end of 2026, the market is projected to be valued at nearly USD 1,900 million, representing an incremental opportunity of more than USD 600 million between 2019 and 2026.

Regional Insights

North America

The North American market for on-the-go breakfast products has shown substantial growth. In 2015, the market was valued at nearly USD 270 million and is expected to reach nearly USD 330 million by the end of 2021. By 2026, the market is anticipated to be valued at approximately USD 415 million, registering a CAGR of 4.4% over the forecast period. This represents an incremental opportunity of nearly USD 150 million between 2019 and 2026.

United States and Canada

In the United States, the on-the-go breakfast products market was valued at nearly USD 200 million in 2015 and is expected to register a CAGR of 4.7% over the forecast period, reaching nearly USD 320 million by the end of 2026. This represents an incremental opportunity of approximately USD 120 million between 2019 and 2026.

In Canada, the market was valued at nearly USD 70 million in 2015 and is expected to witness a CAGR of 3.3% over the forecast period, reaching nearly USD 100 million by the end of 2026. This represents an incremental opportunity of USD 27 million between 2019 and 2026.

Gain Immediate Access to Detailed Market Insights Purchase Now: 

Product Segment Insights

Breakfast Cereals

The breakfast cereals segment was valued at nearly USD 180 million in 2015 and is expected to witness a CAGR of 4.1% over the forecast period, reaching USD 275 million by the end of 2026. This segment is estimated to record an incremental opportunity of more than USD 90 million between 2019 and 2026.

Dairy-Based Breakfast Drinks

The dairy-based breakfast drinks segment was valued at nearly USD 90 million in 2015 and is expected to exhibit a CAGR of 4.8% over the forecast period, reaching a market valuation in excess of USD 140 million by the end of 2026. This segment is estimated to create an incremental opportunity of more than USD 50 million between 2019 and 2026.

Market Segmentation

By Type

  • Breakfast Cereals
  • Dairy-Based Breakfast Drinks

By Distribution Channel

  • Hypermarket/Supermarket
  • Retail Stores
  • Convenience Stores
  • Online Selling
  • Others (Direct Selling)

By Region

  • North America
  • Latin America
  • Eastern Europe
  • Western Europe
  • Asia Pacific Excluding Japan (APEJ)
  • Middle East & Africa (MEA)
  • Japan

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact FMI:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube